Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 4Thoracic 3Breast 3Sarcoma 2Gynecologic 2Other neoplasm 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Head & Neck 1Endocrine 1

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1

Interventions

Oxycodone 2tremelimumab 1penpulimab 1peginterferon alfa-2b 1Zoledronic Acid 1Zidovudine 1Whole-Body Irradiation 1Valproic Acid 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sodium Chloride 1Selenium 1Rosuvastatin Calcium 1Rituximab 1Ribavirin 1Radiosurgery 1Proflavine 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Observation 1Moxifloxacin 1Morphine 1Microarray Analysis 1Methotrexate 1Methadone 1Laser Therapy 1Interferon alpha-2 1Infliximab 1Gene Expression Profiling 1Gadolinium DTPA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Observation × Other neoplasm × Clear all
NCT00118066 2015-05-27

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Rutgers, The State University of New Jersey

Phase 2 Terminated
12 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡